Real-World Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i) in Heterozygous Familial Hypercholesterolemia Patients Referred for Lipoprotein Apheresis

机译：Proprotein转化酶枯草杆菌素/ kexin型9型抑制剂（PCSK9i）的实际疗效在脂蛋白血液蛋白血液蛋白血症患者中

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
作者
Anthony Matta; Vanina Bongard; Frédéric Bouisset; Dorota Taraszkiewicz; Jean-Pierre Rabès; Jean Ferrières;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 7
原文格式 PDF
正文语种
中图分类
关键词
Cholesterol; LDL; Dyslipidemias; Proprotein Convertases;

机译：胆固醇;LDL;腹痘;Proprotein Conversase.;

相似文献

外文文献
中文文献
专利

1. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: The reduction of LDL-C with PCSK9 inhibition in heterozygous familial hypercholesterolemia disorder (RUTHERFORD) randomized trial [J] . RaalF., ScottR., SomaratneR., Circulation: An Official Journal of the American Heart Association . 2012,第20期

机译：AMG 145的低密度脂蛋白胆固醇降低作用，对杂合子家族性高胆固醇血症患者的前蛋白转化酶枯草杆菌蛋白酶/ kexin 9型丝氨酸蛋白酶的单克隆抗体：PCSK9抑制可降低LDL-C对杂合子家族性高胆固醇血症（RUTHERFORD）的影响试用
2. Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways [J] . CameronJ., BogsrudM.P., TvetenK., Translational research: the journal of laboratory and clinical medicine . 2012,第2期

机译：家族性高胆固醇血症患者的血清原蛋白转化酶枯草杆菌蛋白酶/ kexin 9型水平表明通过低密度脂蛋白受体非依赖性途径从血浆中清除了原蛋白转化酶枯草杆菌蛋白酶/ kexin 9型
3. Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia [J] . Kastelein John J. P., Hovingh G. Kees, Langslet Gisle, Journal of clinical lipidology . 2017,第1期

机译：Proprotein转化酶枯草杆菌蛋白酶/ kexin型9型单克隆抗体Alirocumab与安慰剂的疗效和安全性在杂合子家族性高胆固醇血症患者中
4. Towards Investigating the Role of Proprotein Convertase Subtilisin/Kexin Family (PCSK/7/9) in Cancer by Using Bioinformatics Motif Detection Technique [C] . Umar Draz, Sana Yasin, Shafiq Hussain, International Bhurban Conference on Applied Sciences and Technologies . 2021

机译：通过使用生物信息学主题检测技术来研究Proprotein转化酶枯草杆菌素/ kexin家族（PCSK / 7/9）的作用
5. Evaluation of the Interaction Between Proprotein Convertase Subtilisin/Kexin Type 9 and Sterol Carrier Protein-2 [D] . Ahranjani, Reza. 2017

机译：评价前蛋白转化酶枯草杆菌蛋白酶/ Kexin 9型与甾醇载体蛋白2的相互作用。
6. Efficacy and safety of proprotein convertase subtilisin/kexin type 9 monoclonal antibody in adults with familial hypercholesterolemia [O] . Bin Li, Pan-Pan Hao, Yong Zhang, 2017

机译：前蛋白转化酶枯草杆菌蛋白酶/ kexin 9型单克隆抗体在成人家族性高胆固醇血症中的疗效和安全性
7. Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia [O] . Kastelein, John J. P., Hovingh, G. Kees, Langslet, Gisle, 2017

机译：前蛋白转化酶枯草杆菌蛋白酶/ kexin 9型单克隆抗体alirocumab与安慰剂在杂合性家族性高胆固醇血症患者中的疗效和安全性

Real-World Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i) in Heterozygous Familial Hypercholesterolemia Patients Referred for Lipoprotein Apheresis

著录项

引文网络

相似文献

相关主题

期刊订阅